JAMA

© Reuters Lilly (LLY) Announces Results from Landmark Phase 3 Trial of Donanemab Presented at Alzheimer's Association…
Read More...

In the short term, Indian equities are likely to be rangebound amid the global economic situation, but the long-term…
Read More...

<!-- Name:DistributionId Value:8746384 --> <!--…
Read More...

A theme issue in this…
Read More...

First study of an anti-Abeta vaccine in people living with Down syndrome (DS) Immune response and Alzheimer’s disease…
Read More...

Kirsten Bibbins-Domingo,…
Read More...

With the exception of the…
Read More...

New Delhi, December 19 In the famed bylanes of Old Delhi’s Jama…
Read More...

LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology…
Read More...

A controversial study…
Read More...